Literature DB >> 15320995

Identification and genomic sequence of an HIV type 1 group N isolate from Cameroon.

Pierre Bodelle1, Ana Vallari, Ruthie Coffey, Carole P McArthur, Mathilde Beyeme, Sushil G Devare, Gerald Schochetman, Catherine A Brennan.   

Abstract

HIV-infected plasma specimens, collected in Cameroon between 1999 and 2002, were screened for HIV-1 group N and SIVcpz infections using a serological screening algorithm based on immunoassays with antigens derived from HIV-1 group M, N, and O, and SIVcpz strains. Specimens with reactivity to group N and SIVcpz antigens were characterized by RT-PCR and sequence analysis to identify the infecting virus. Although several specimens were serotyped as potential group N or SIVcpz infections, only one group N infection was confirmed. The specimen, 02CM-DJO0131, was collected in 2002 from a hospital patient at the D'Joungolo Hospital, Yaoundé. The virus genome was amplified as seven overlapping fragments comprising 8938 nucleotides. Phylogenetic analysis shows that 02CM-DJO0131 branches with group N sequences. With this study, three near full-length sequences are now available for group N. While we confirm the presence of group N in the Cameroonian population, group N infections continue to be rare and difficult to identify.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15320995     DOI: 10.1089/0889222041725262

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  13 in total

1.  IFI16 Targets the Transcription Factor Sp1 to Suppress HIV-1 Transcription and Latency Reactivation.

Authors:  Dominik Hotter; Matteo Bosso; Kasper L Jønsson; Christian Krapp; Christina M Stürzel; Atze Das; Elisabeth Littwitz-Salomon; Ben Berkhout; Alina Russ; Sabine Wittmann; Thomas Gramberg; Yue Zheng; Laura J Martins; Vicente Planelles; Martin R Jakobsen; Beatrice H Hahn; Ulf Dittmer; Daniel Sauter; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2019-06-04       Impact factor: 21.023

2.  Phylodynamics of the HIV-1 CRF02_AG clade in Cameroon.

Authors:  Nuno R Faria; Marc A Suchard; Ana Abecasis; João D Sousa; Nicaise Ndembi; Idalina Bonfim; Ricardo J Camacho; Anne-Mieke Vandamme; Philippe Lemey
Journal:  Infect Genet Evol       Date:  2011-05-04       Impact factor: 3.342

Review 3.  Going wild: lessons from naturally occurring T-lymphotropic lentiviruses.

Authors:  Sue VandeWoude; Cristian Apetrei
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

4.  Autocatalytic maturation, physical/chemical properties, and crystal structure of group N HIV-1 protease: relevance to drug resistance.

Authors:  Jane M Sayer; Johnson Agniswamy; Irene T Weber; John M Louis
Journal:  Protein Sci       Date:  2010-11       Impact factor: 6.725

5.  Enhanced nicotine metabolism in HIV-1-positive smokers compared with HIV-negative smokers: simultaneous determination of nicotine and its four metabolites in their plasma using a simple and sensitive electrospray ionization liquid chromatography-tandem mass spectrometry technique.

Authors:  Ravinder Earla; Anusha Ande; Carole McArthur; Anil Kumar; Santosh Kumar
Journal:  Drug Metab Dispos       Date:  2013-12-03       Impact factor: 3.922

Review 6.  Simian immunodeficiency virus infection of chimpanzees.

Authors:  Paul M Sharp; George M Shaw; Beatrice H Hahn
Journal:  J Virol       Date:  2005-04       Impact factor: 6.549

7.  HIV Genetic Diversity and Drug Resistance.

Authors:  André F Santos; Marcelo A Soares
Journal:  Viruses       Date:  2010-02-02       Impact factor: 5.818

8.  Lack of adaptation to human tetherin in HIV-1 group O and P.

Authors:  Su Jung Yang; Lisa A Lopez; Colin M Exline; Kevin G Haworth; Paula M Cannon
Journal:  Retrovirology       Date:  2011-09-28       Impact factor: 4.602

9.  Fatal HIV encephalitis in HIV-seronegative patients.

Authors:  Troy M Martin; Josiah D Rich
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

10.  Human tetherin exerts strong selection pressure on the HIV-1 group N Vpu protein.

Authors:  Daniel Sauter; Daniel Unterweger; Michael Vogl; Shariq M Usmani; Anke Heigele; Silvia F Kluge; Elisabeth Hermkes; Markus Moll; Edward Barker; Martine Peeters; Gerald H Learn; Frederic Bibollet-Ruche; Joëlle V Fritz; Oliver T Fackler; Beatrice H Hahn; Frank Kirchhoff
Journal:  PLoS Pathog       Date:  2012-12-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.